Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma
出版年份 2021 全文链接
标题
Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma
作者
关键词
-
出版物
BMC CANCER
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-11-11
DOI
10.1186/s12885-021-08911-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
- (2020) Yaqing Zhang et al. Cancer Discovery
- An Immunological Glance on Pancreatic Ductal Adenocarcinoma
- (2020) Michael Karl Melzer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
- (2020) Reem Saleh et al. CANCER LETTERS
- The role of genetic polymorphism within PD-L1 gene in cancer. Review
- (2020) Agnieszka Kula et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Mechanisms of T-Cell Exhaustion in Pancreatic Cancer
- (2020) Didem Saka et al. Cancers
- Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
- (2020) Yizhi Wang et al. Frontiers in Oncology
- Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
- (2020) Minoru Oshima et al. BMC GASTROENTEROLOGY
- PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
- (2019) Yongshuai Jiang et al. Human Vaccines & Immunotherapeutics
- Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer
- (2019) Ke Zhang et al. Journal of Translational Medicine
- Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features
- (2019) Eva Karamitopoulou BRITISH JOURNAL OF CANCER
- Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer
- (2019) Sayumi Yoshida et al. CANCER INVESTIGATION
- Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment
- (2019) Sireesha Upadhrasta et al. Journal of Clinical Medicine
- PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
- (2019) Jiaqiang Ma et al. Journal for ImmunoTherapy of Cancer
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- High immune cell score predicts improved survival in pancreatic cancer
- (2018) Kyösti Tahkola et al. VIRCHOWS ARCHIV
- Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
- (2018) Jiajia Zhang et al. Cancers
- Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
- (2018) Ujjwal Mukund Mahajan et al. GASTROENTEROLOGY
- Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides
- (2018) Jun Nakata et al. Oncotarget
- PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
- (2017) Sylvain Simon et al. OncoImmunology
- Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
- (2016) Andrea Schietinger et al. IMMUNITY
- Wilms’ tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer
- (2016) Shigeo Koido et al. Immunotherapy
- Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3+)/activated cytotoxic T lymphocyte (granzyme B+) ratio on resected left-sided pancreatic cancer
- (2016) Ho Kyoung Hwang et al. Oncology Letters
- Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer
- (2016) Yu Wang et al. Oncotarget
- Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma
- (2016) Angela Diana et al. Oncotarget
- Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
- (2015) N Hiraoka et al. BRITISH JOURNAL OF CANCER
- In-situ tumor vaccination: Bringing the fight to the tumor
- (2015) Robert H Pierce et al. Human Vaccines & Immunotherapeutics
- Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
- (2015) Giovanni Francesco Castino et al. OncoImmunology
- Abstract CT218: Wilms′ tumor gene 1 (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer
- (2015) Shigeo Koido et al. CANCER RESEARCH
- Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer
- (2014) S. Koido et al. CLINICAL CANCER RESEARCH
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Chemoimmunotherapy targeting Wilms’ tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer
- (2014) Shigeo Koido et al. OncoImmunology
- Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
- (2013) Y Ino et al. BRITISH JOURNAL OF CANCER
- Current Immunotherapeutic Approaches in Pancreatic Cancer
- (2011) Shigeo Koido et al. Clinical & Developmental Immunology
- Circulating CD4+CD25+ Regulatory T Cells in Patients With Pancreatic Cancer
- (2011) Tomohisa Yamamoto et al. PANCREAS
- CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study
- (2009) Luigi Laghi et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now